2023 Crossroads Conference Recap
We are so thankful to all who attended and supported Crossroads 2023. We had an incredible time together!
Please enjoy our recap of the 2023 conference. More photos can be found on artiacrossroads.com.
More than 530 attendees gathered at the downtown JW Marriott in Nashville, Tennessee, on June 12-14, 2023, for the third Crossroads: An Artia Solutions Conference.
We kicked off Crossroads 2023 on Broadway at Acme Feed & Seed for our Opening Night Reception. We hosted 32 Speed Networking stakeholders, 31 speakers, 25 state pharmacy directors and staff, 8 advocacy groups, 7 sessions, and 5 panel discussions. Our agenda highlighted the patient journey, which included crucial Medicaid topics such as accelerated approval, high-cost drug therapies, AMP Cap removal, and much more.
We also held three Speed Networking sessions – the most appointments we’ve organized yet! Speed Networking is our way of making business connections as seamless as possible. Our coordinators facilitate semi-private appointments between manufacturers and pharmacy benefit managers, state Medicaid pharmacy directors, Managed Medicaid officials, and other Medicaid stakeholders.
Terry Cothran, Senior Pharmacy Director, Oklahoma Health Care Authority; and Joshua Moore, Director of Pharmacy, MO HealthNet Division; were awarded the 2023 Extra Mile Award during the Extra Mile Award Banquet on Tuesday, June 13. The Extra Mile Award is a special honor created to recognize former or current Medicaid officials and/or pharmacy benefit managers who have shown continuous effort in doing or achieving something above what is expected.
Cheers to Crossroads 2025! Date and location TBA.
Changes to New York’s Rebate Programs
Manufacturers are often intimidated when directed by New York to participate in Medicaid, due to the uniqueness of their programs. We aim to eliminate confusion in navigating these processes to resolution. In this blog post, we’ll walk you through a summary of the most recent changes to the New York Medicaid programs.
State Medicaid Programs Retake Pharmacy Controls
State Medicaid programs’ relationships with managed care organizations that serve Medicaid recipients continue to evolve. Just when it appears that trends are slowing or stabilizing, a new method is introduced. The latest development could overlap existing state controls to bring even more pharmacy control back to state management.
Reimbursement Challenges with High-Cost Inpatient Drugs
The management and reimbursement of inpatient drug costs in Medicaid programs are pivotal topics, especially with the proliferation of high-cost therapies. The emergence of expensive inpatient drugs, such as cell and gene therapies, have challenged Diagnosis Related Groups (DRGs), the traditional bundled payment system used by hospitals.